Quarterly ResultJul 31, 2026, 06:12 AM
BrightSpring Q2 Revenue $3.87B, Adj. EBITDA $206M; Raises FY26 Guidance
AI Summary
BrightSpring Health Services, Inc. reported strong financial results for the second quarter ended June 30, 2026, with net revenue increasing 23.0% to $3,873 million and Adjusted EBITDA growing 44.2% to $206 million. The company also significantly increased its full-year 2026 guidance for both revenue and Adjusted EBITDA, reflecting confidence in its operational execution. Additionally, BrightSpring completed a $300.0 million debt paydown and repurchased $60.0 million in common stock.
Key Highlights
- Q2 2026 Net revenue increased 23.0% year-over-year to $3,873 million.
- Q2 2026 Gross profit rose 31.5% year-over-year to $493 million.
- Q2 2026 Net income was $87 million, up from $9 million in Q2 2025.
- Q2 2026 Adjusted EBITDA grew 44.2% year-over-year to $206 million.
- Increased full-year 2026 Revenue guidance to $15,100 million to $15,425 million.
- Increased full-year 2026 Adjusted EBITDA guidance to $820 million to $845 million.
- Completed a $300.0 million paydown of the First Lien Facility.
- Repurchased 1,026,465 shares of common stock for $60.0 million.
Price Impact
More from BTSG